Danish biotech company granted millions to develop custom-made cancer vaccine

Innovation Fund Denmark has granted a small Danish biotech company millions to develop a cancer vaccine targeting the unique cell changes in the individual patient. If the company succeeds, it will enter a billion-dollar market.

Photo: Evaxion, PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles